Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03325946 · ClinicalTrials.gov registry record
The FBRI VTC Neuromotor Research Clinic
A clinical trial of Autism and Cerebral Palsy, sponsored by Virginia Polytechnic Institute and State University.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT03325946: Recruiting study of Autism and Cerebral Palsy, sponsored by Virginia Polytechnic Institute and State University.
NCT03325946 is a study of Autism and Cerebral Palsy that is actively recruiting participants, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 500 participants, above the 179-participant average among 104 other Autism trials with a reported enrollment target (179% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03325946, a study of Autism and Cerebral Palsy, is actively recruiting participants, sponsored by Virginia Polytechnic Institute and State University.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The FBRI VTC Neuromotor Research Clinic was established and opened in May of 2013 to provide intensive therapeutic services to individuals with motor impairment secondary to neuromotor disorders. It is direct by Dr. Stephanie DeLuca and based on the principles surrounding ACQUIREc Therapy. ACQUIREc Therapy is an evidenced-based approach to pediatric constraint-induced movement therapy, which refers to a multi-component form of therapy that is focused on helping children who have asymmetric motor abilities between the two sides of the body. Historically, ACQUIREc Therapy has the unimpaired or less impaired upper extremity constrained (by a cast or a splint) while also receiving active therapy from a specially trained therapist who shapes new skills and functional activities with the child's more impaired upper extremity but who is also a licensed Occupational or Physical Therapist (OT/PT). Therapy dosages are high much higher than tradition OT or PT - often lasting many hours per day, up to 6 hours a day, 5 days a week, for 2-4 weeks. Investigators have developed further treatments based on the same principles of intensive services combined with behavior shaping for other areas of the body that are also affected by weakness (e.g., the leg and trunk) also, but which usually do not involve constraint. These have been more generally labeled ACQUIRE Therapy. All forms involve intensive, play-based therapy for children with asymmetric motor impairments of the arms and hands. The primary focus of treatment is to facilitate the acquisition of new motor skills in the child's weaker body parts through high levels of intensive therapy using scientifically-based behavioral guidelines. Therapy is also delivered in naturalistic environments. ACQUIREc Therapy as a treatment method has been tested in two randomized controlled trials, and a specific manual for its implementation has been developed. Dr. (s) Ramey and DeLuca previously founded a similar clinic, The Pediatric Neuro
Primary Outcome
This is a measure of the number of skills a child uses from a set of 31 typical used on a daily basis
Conditions Studied
Interventions
- BEHAVIORAL ACQUIRE Therapy
Study Locations (1)
Virginia
- Fralin Biomedical Research Institute - VTC - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2013-01-01 |
| Est. Completion | 2029-12-31 |
What NCT03325946 shows while recruiting
NCT03325946 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 179-participant average among 104 other Autism trials with a reported enrollment target (179% higher).
The record links to 7 conditions, with Autism appearing as the primary indexed condition, and to 1 intervention - of which ACQUIRE Therapy is the first listed.
NCT03325946 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT03325946 about?
NCT03325946 is a clinical study titled "The FBRI VTC Neuromotor Research Clinic". The FBRI VTC Neuromotor Research Clinic was established and opened in May of 2013 to provide intensive therapeutic services to individuals with motor impairment secondary to neuromotor disorders. It is direct by Dr. Stephanie DeLuca and based on the principles surrounding ACQUIREc Therapy. ACQUIREc...
What is the current status of trial NCT03325946?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2013-01-01. Estimated completion is 2029-12-31.
What conditions does trial NCT03325946 study?
This clinical trial studies the following conditions: Autism, Cerebral Palsy, Acquired Brain Injury, Microcephaly, Trauma, Brain.
What interventions are being tested in trial NCT03325946?
The interventions under investigation include: ACQUIRE Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03325946?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03325946 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03325946's enrollment target sits among peer trials
500 6th of 104 higher than 99 of 104 other Autism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
RECRUITING · NA
-
Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism
RECRUITING · NA
-
Optimizing Outcomes for Young Autistic Children
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI